Holders — by stockHoldings — by fund
Bronte Capital Management Pty Ltd.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001471085
$997.0M
disclosed book value
56
positions
12.6%
largest position share
Positions, as of 2026-09-30
top 57 of 56 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | REGNREGENERON PHARMACEUTICALS | 165,070 | $125.2M | 12.6% |
| 2 | GOOGLALPHABET INC | 294,414 | $101.3M | 10.2% |
| 3 | VISA INC-CLASS A SHARES | 219,697 | $78.9M | 7.9% |
| 4 | BRK/BBERKSHIRE HATHAWAY INC DEL | 152,978 | $76.2M | 7.6% |
| 5 | IBKRINTERACTIVE BROKERS GROUP | 879,553 | $75.1M | 7.5% |
| 6 | AMZNAMAZON COM INC | 273,201 | $68.1M | 6.8% |
| 7 | PMPHILIP MORRIS INTL INC | 304,952 | $58.2M | 5.8% |
| 8 | REGNREGENERON PHARMACEUTICALSCALL | 68,600 | $52.0M | 5.2% |
| 9 | DISDISNEY WALT CO | 385,659 | $40.5M | 4.1% |
| 10 | CTVACORTEVA INC | 464,308 | $36.1M | 3.6% |
| 11 | COFCAPITAL ONE FINL CORP | 176,737 | $34.1M | 3.4% |
| 12 | FCNCAFIRST CTZNS BANCSHARES INC N | 14,417 | $29.7M | 3% |
| 13 | TBBBBBB FOODS INC | 542,490 | $28.6M | 2.9% |
| 14 | IHGINTERCONTINENTAL HOTELS GROU | 134,324 | $21.7M | 2.2% |
| 15 | VANECK ETF TRUST | 193,275 | $17.0M | 1.7% |
| 16 | SOTERA HEALTH CO | 806,488 | $14.9M | 1.5% |
| 17 | IBBISHARES TR | 66,212 | $13.9M | 1.4% |
| 18 | BF/BBROWN FORMAN CORP | 529,314 | $13.9M | 1.4% |
| 19 | GHCGRAHAM HLDGS CO | 11,653 | $13.2M | 1.3% |
| 20 | NKTRNEKTAR THERAPEUTICS | 202,057 | $12.2M | 1.2% |
| 21 | GLBEGLOBAL E ONLINE LTD | 231,450 | $9.2M | 0.9% |
| 22 | ALNYALNYLAM PHARMACEUTICALS INC | 35,708 | $8.8M | 0.9% |
| 23 | NEMNEWMONT CORP | 70,213 | $8.1M | 0.8% |
| 24 | SQMSOCIEDAD QUIMICA Y MINERA DE | 117,370 | $7.6M | 0.8% |
| 25 | BBARRICK MNG CORP | 147,771 | $6.0M | 0.6% |
| 26 | AURAURORA INNOVATION INC | 940,111 | $5.2M | 0.5% |
| 27 | RSKDRISKIFIED LTD | 600,398 | $4.7M | 0.5% |
| 28 | HLFHERBALIFE NUTRITION LTD | 329,397 | $4.0M | 0.4% |
| 29 | RVMDREVOLUTION MEDICINES INC | 18,977 | $3.9M | 0.4% |
| 30 | RAMPLIVERAMP HLDGS INC | 91,647 | $3.4M | 0.3% |
| 31 | IJRISHARES TR | 23,419 | $3.2M | 0.3% |
| 32 | MDLZMONDELEZ INTL INC | 52,613 | $3.0M | 0.3% |
| 33 | VANECK ETF TRUST | 24,661 | $2.8M | 0.3% |
| 34 | TYLTYLER TECHNOLOGIES INC | 8,454 | $2.7M | 0.3% |
| 35 | PCTYPAYLOCITY HLDG CORP | 18,209 | $2.6M | 0.3% |
| 36 | BF/ABROWN FORMAN CORP | 96,294 | $2.6M | 0.3% |
| 37 | TPBTURNING PT BRANDS INC | 41,036 | $2.4M | 0.2% |
| 38 | BBWIBATH & BODY WORKS INC | 144,529 | $2.3M | 0.2% |
| 39 | NICENICE LTD | 16,521 | $1.8M | 0.2% |
| 40 | OLEDUNIVERSAL DISPLAY CORP | 10,292 | $792,896 | 0.1% |
| 41 | VRSKVERISK ANALYTICS INC | 2,667 | $447,656 | 0% |
| 42 | TMCITREACE MED CONCEPTS INC | 15,577 | $69,162 | 0% |
| 43 | ANTXAN2 THERAPEUTICS INC | 10,895 | $57,961 | 0% |
| 44 | ENVXENOVIX CORPORATION | 41,765 | $56,286 | 0% |
| 45 | FATEFATE THERAPEUTICS INC | 21,740 | $51,524 | 0% |
| 46 | PEPGPEPGEN INC | 17,776 | $43,018 | 0% |
| 47 | PACBPACIFIC BIOSCIENCES CALIF IN | 17,881 | $42,378 | 0% |
| 48 | CCCCC4 THERAPEUTICS INC | 10,349 | $34,462 | 0% |
| 49 | SEERSEER INC | 15,109 | $33,693 | 0% |
| 50 | CMRCCOMMERCE.COM INC | 10,278 | $32,478 | 0% |
| 51 | ALXOALX ONCOLOGY HLDGS INC | 18,095 | $25,152 | 0% |
| 52 | ABOSACUMEN PHARMACEUTICALS INC | 10,716 | $23,790 | 0% |
| 53 | ALECALECTOR INC | 11,758 | $21,752 | 0% |
| 54 | BLNDBLEND LABS INC | 19,247 | $19,824 | 0% |
| 55 | CHRSCOHERUS ONCOLOGY INC | 15,262 | $18,467 | 0% |
| 56 | NBPNOVABRIDGE BIOSCIENCES | 11,192 | $15,277 | 0% |
| 57 | MISTMILESTONE PHARMACEUTICALS IN | 14,390 | $12,457 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.